Author:
Xu Yue-Juan,Wang Jian,Xu Rang,Zhao Peng-Jun,Wang Xi-Ke,Sun Heng-Juan,Bao Li-Ming,Shen Jie,Fu Qi-Hua,Li Fen,Sun Kun
Abstract
Abstract
Background
Conotruncal heart defects (CTDs) are present in 75-85% of patients suffering from the 22q11.2 deletion syndrome. To date, no consistent phenotype has been consistently correlated with the 22q11.2 deletions. Genetic studies have implicated TBX1 as a critical gene in the pathogenesis of the syndrome. The aim of study was to determine the incidence of the 22q11.2 deletion in Chinese patients with CTDs and the possible mechanism for pathogenesis of CTDs.
Methods
We enrolled 212 patients with CTDs and 139 unrelated healthy controls. Both karyotypic analysis and multiplex ligation-dependent probe amplification were performed for all CTDs patients. Fluorescence in situ hybridization was performed for the patients with genetic deletions and their relatives. The TBX1 gene was sequenced for all patients and healthy controls. The χ
2 and Fisher's exact test were used in the statistical analysis.
Results
Thirteen of the 212 patients with CTDs (6.13%) were found to have the 22q11.2 deletion syndrome. Of the 13 cases, 11 presented with a hemizygous interstitial microdeletion from CLTCL1 to LZTR1; one presented with a regional deletion from CLTCL1 to DRCR8; and one presented with a regional deletion from CDC45L to LZTR1. There were eight sequence variants in the haploid TBX1 genes of the del22q11 CTDs patients. The frequency of one single nucleotide polymorphism (SNP) in the del22q11 patients was different from that of the non-del patients (P < 0.05), and the frequencies of two other SNPs were different between the non-del CTDs patients and controls (P < 0.05).
Conclusions
CTDs, especially pulmonary atresia with ventricular septal defect and tetralogy of Fallot, are the most common disorders associated with the 22q11.2 deletion syndrome. Those patients with both CTDs and 22q11.2 deletion generally have a typical or atypical deletion region within the TBX1 gene. Our results indicate that TBX1 genetic variants may be associated with CTDs.
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference34 articles.
1. Conti E, Grifone N, Sarkozy A, Tandoi C, Marino B, Digilio MC, Mingarelli R, Pizzuti A, Dallapiccola B: DiGeorge subtypes of nonsyndronmic conotruncal defects: evidence against a major role of TBX1 gene. Eur J Hum Genetic. 2003, 11 (4): 349-351. 10.1038/sj.ejhg.5200956.
2. Derbent M, Yilmaz Z, Baltaci V, Saygili A, Varan B, Tokel K: Chromosome 22q11.2 deletion and phenotypic features in 30 patients with conotruncal heart defects. Am J Med Genet. 2003, 116A (2): 129-135. 10.1002/ajmg.a.10832.
3. Devriendt K, Eyskens B, Swillen A, Dumoulin M, Gewillig M, Fryns JP: The incidence of a deletion in chromosome 22q11 in sporadic and familial conotruncal heart disease. Eur J Pediatr. 1996, 155 (8): 721-10.1007/BF01957162.
4. Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L, McDonald-McGinn D, Chien P, Feuer J, Zackai EH, Emanuel BS, Driscoll DA: Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol. 1998, 32 (2): 492-498. 10.1016/S0735-1097(98)00259-9.
5. Marino B, Digilio MC, Toscano A, Giannotti A, Dallapiccola B: Congenital heart defects in patients with DiGeorge/velocardiofacial syndrome and del22q11. Genet Couns. 1999, 10 (1): 25-33.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献